AbbVie
ABBV
#25
Rank
ยฃ392.13 B
Marketcap
ยฃ221.85
Share price
-0.59%
Change (1 day)
24.73%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

EPS for AbbVie (ABBV)

EPS in 2026 (TTM): ยฃ4.40

According to AbbVie's latest financial reports the company's current EPS (TTM) is ยฃ4.43. In 2025 the company made an earnings per share (EPS) of ยฃ1.79 a decrease over its 2024 EPS that were of ยฃ1.83.

EPS history for AbbVie from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)ยฃ4.40145.45%
2025ยฃ1.79-2.26%
2024ยฃ1.83-11.86%
2023ยฃ2.08-58.95%
2022ยฃ5.072.49%
2021ยฃ4.95121.58%
2020ยฃ2.23-44.7%
2019ยฃ4.0445.84%
2018ยฃ2.779.72%
2017ยฃ2.52-9.54%
2016ยฃ2.7916.28%
2015ยฃ2.40184.1%
2014ยฃ0.84-57.15%
2013ยฃ1.97

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
ยฃ0.54-87.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
ยฃ23.40 427.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ13.17 197.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ1.79-59.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
-ยฃ2.35-152.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ3.42-22.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ5.39 21.68%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ2.18-50.83%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
ยฃ5.28 19.11%๐Ÿ‡บ๐Ÿ‡ธ USA